(Q35176348)

6 August 2017

1 reference

title

The TNF receptor superfamily: role in immune inflammation and bone formation (English)

1 reference

6 August 2017

Xin Cheng

1

1 reference

6 August 2017

Masa Kinosaki

series ordinal

2

1 reference

6 August 2017

Ramachandran Murali

series ordinal

3

1 reference

6 August 2017

Mark I Greene

series ordinal

4

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

27

1 reference

6 August 2017

issue

2-3

1 reference

6 August 2017

page(s)

287-294

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:27:2-3:287

6 August 2017

exact match

0 references

cites work

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

1 reference

12 December 2020

Bone resorption by osteoclasts

1 reference

12 December 2020

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

12 December 2020

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 December 2020

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

1 reference

12 December 2020

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

12 December 2020

Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.

1 reference

12 December 2020

Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor

1 reference

12 December 2020

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro

1 reference

12 December 2020

Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.

1 reference

12 December 2020

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast

1 reference

12 December 2020

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

12 December 2020

TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL

1 reference

12 December 2020

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

12 December 2020

The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation

1 reference

12 December 2020

Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

12 December 2020

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

1 reference

12 December 2020

Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

1 reference

12 December 2020

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

1 reference

12 December 2020

Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor

1 reference

12 December 2020

Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development.

1 reference

12 December 2020

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

12 December 2020

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

1 reference

12 December 2020

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

1 reference

12 December 2020

Structure-based design of immunologically active therapeutic peptides

1 reference

12 December 2020

Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

1 reference

12 December 2020

Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

1 reference

12 December 2020

Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity

1 reference

12 December 2020

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

1 reference

12 December 2020

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

12 December 2020

NF-kappaB at the crossroads of life and death

1 reference

12 December 2020

RANK-L and RANK: T cells, bone loss, and mammalian evolution

1 reference

12 December 2020

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

12 December 2020

Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity

1 reference

12 December 2020

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

1 reference

12 December 2020

Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis

1 reference

12 December 2020

The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily

1 reference

12 December 2020

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

1 reference

12 December 2020

Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)

1 reference

12 December 2020

Therapeutic peptides and peptidomimetics

1 reference

12 December 2020

Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture

1 reference

12 December 2020

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

12 December 2020

Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation

1 reference

12 December 2020

Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases

1 reference

12 December 2020

Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism

1 reference

12 December 2020

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

1 reference

12 December 2020

Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor

1 reference

12 December 2020

Death receptors: signaling and modulation

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:27:2-3:287

1 reference

Dimensions Publication ID

6 August 2017

1032464398

0 references

1 reference